Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazolinone Derivative. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108101904B reveals a copper-catalyzed route for quinolinoquinazolinone derivatives, offering high yields and scalable production for anti-tumor pharmaceutical intermediates.
Patent CN115850193B details copper-catalyzed quinazolinone synthesis offering high yield and selectivity for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN108033919B details a novel Pd-catalyzed oxidative cleavage route using styrenes, offering cost-effective manufacturing for high-purity pharmaceutical intermediates.
Patent CN105732521B reveals a metal-free TEMPO catalytic route for dihydroquinazolinone derivatives, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1042914A reveals a high-yield route for spiro-quinazolinone derivatives. Discover cost-effective manufacturing strategies for diabetic complication intermediates.
Patent CN106496146A reveals a sulfonic acid ionic liquid catalyzed method for high-yield quinazolinone synthesis, offering cost reduction and supply chain reliability for pharma intermediates.
Advanced one-pot synthesis of quinazolinone derivatives using aqueous copper catalysis. Discover cost-effective manufacturing and high-purity supply chain solutions.
Discover a green, visible-light mediated method for synthesizing phosphorylated quinazolinone compounds. This novel route offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111592549B reveals a novel Rh-catalyzed [4+1] cyclization for quinazolinone derivatives, offering streamlined synthesis and cost reduction in API manufacturing.
Patent CN112480015B reveals a mild one-pot synthesis for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN111675662B reveals a novel iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN112480015B details a one-pot method for quinazolinones, offering cost-effective routes for pharmaceutical intermediates and improved supply chain reliability.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Novel Pd-catalyzed carbonylation method for quinazolinones using solid CO source. Safe, high-yield, scalable process for API intermediates and fine chemicals.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN112125856A details a novel Pd-catalyzed carbonylation for 2-trifluoromethyl quinazolinones, offering safer synthesis and cost reduction in API manufacturing.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. High yield, scalable process for API intermediates. Cost-effective supply chain solution.
Patent CN112125856A details a safe, scalable synthesis of 2-trifluoromethyl quinazolinones using solid CO surrogates, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN112480015B details a scalable one-pot method for 2-trifluoromethyl quinazolinones, offering cost reduction in pharmaceutical intermediate manufacturing via safe carbonylation.